Dry eye and designer ophthalmics

Optometry and Vision Science

Volumn 85, Issue 8, 2008, Pages 643-652

  Laurie, Gordon W ^a,e   Olsakovsky, Leslie A ^a   Conway, Brian P ^a   McKown, Robert L ^b   Kitagawa, Kazuko ^c   Nichols, Jason J ^d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b JAMES MADISON UNIVERSITY   (United States)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d OHIO STATE UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dry eye; Lacritin; Personalized medicine; Proteomics; Tears

Indexed keywords

DRY EYE; LACRITIN; PERSONALIZED MEDICINE; PROTEOMICS; TEARS;

ANTIBODIES; ENZYME ACTIVITY;

MOLECULAR BIOLOGY;

CELL PROTEIN; PROTEOME; RECOMBINANT PROTEIN; TEAR PROTEIN; DESIGNER DRUG; EYE DROPS; EYE PROTEIN; TEAR PROTEINS;

ARTICLE; CONSENSUS; DRY EYE; EYE DISEASE; HUMAN; OPHTHALMOLOGY; PRIORITY JOURNAL; PROTEOMICS; SYSTEMS BIOLOGY; TURNOVER TIME; LACRIMAL FLUID; METABOLISM; PHYSIOLOGY;

DESIGNER DRUGS; DRY EYE SYNDROMES; EYE PROTEINS; HUMANS; OPHTHALMIC SOLUTIONS; PROTEOME; RECOMBINANT PROTEINS; TEARS;

EID: 52049123170     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e318181ae73     Document Type: Article

References (87)

1. Baier G, Wollensak G, Mur E, Redl B, Stoffler G, Gottinger W. Analysis of human tear proteins by different high-performance liquid chromatographic techniques. J Chromatogr 1990;525:319-28.
2. Van Haeringen NJ. Clinical biochemistry of tears. Surv Ophthalmol 1981;26:84-96.
3. Holly FJ, Hong BS. Biochemical and surface characteristics of human tear proteins. Am J Optom Physiol Opt 1982;59:43-50.
4. Janssen PT, Van Bijsterveld OP. Comparison of electrophoretic techniques for the analysis of human tear fluid proteins. Clin Chim Acta 1981;114:207-18.
5. Sack RA, Conradi L, Krumholz D, Beaton A, Sathe S, Morris C. Membrane array characterization of 80 chemokines, cytokines, and growth factors in open-and closed-eye tears: angiogenin and other defense system constituents. Invest Ophthalmol Vis Sci 2005;46:1228-38.
6. Jauhiainen M, Setala NL, Ehnholm C, Metso J, Tervo TM, Eriksson O, Holopainen JM. Phospholipid transfer protein is present in human tear fluid. Biochemistry 2005;44:8111-16.
7. Nava A, Barton K, Monroy DC, Pflugfelder SC. The effects of age, gender, and fluid dynamics on the concentration of tear film epidermal growth factor. Cornea 1997;16:430-8.
8. Rocha EM, Cunha DA, Carneiro EM, Boschero AC, Saad MJ, Velloso LA. Identification of insulin in the tear film and insulin receptor and IGF-1 receptor on the human ocular surface. Invest Ophthalmol Vis Sci 2002;43:963-7.
9. Kimata H. Passive smoking elevates neurotrophin levels in tears. Hum Exp Toxicol 2004;23:215-17.
10. Barton K, Nava A, Monroy DC, Pflugfelder SC. Cytokines and tear function in ocular surface disease. Adv Exp Med Biol 1998;438:461-9.
11. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 2001;42:2283-92.
12. Thakur A, Willcox MD. Cytokine and lipid inflammatory mediator profile of human tears during contact lens associated inflammatory diseases. Exp Eye Res 1998;67:9-19.
13. Lema I, Duran JA. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology 2005;112:654-9.
14. Afonso AA, Monroy D, Stern ME, Feuer WJ, Tseng SC, Pflugfelder SC. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology 1999;106:803-10.
15. Holopainen JM, Moilanen JA, Sorsa T, Kivela-Rajamaki M, Tervahartiala T, Vesaluoma MH, Tervo TM. Activation of matrix metalloproteinase-8 by membrane type 1-MMP and their expression in human tears after pho-torefractive keratectomy. Invest Ophthalmol Vis Sci 2003;44:2550-6.
16. Smith VA, Rishmawi H, Hussein H, Easty DL. Tear film MMP accumulation and corneal disease. Br J Ophthalmol 2001;85: 147-53.
17. Vita JB, Anderson JA, Hulem CD, Leopold IH. Angiotensin-converting enzyme activity in ocular fluids. Invest Ophthalmol Vis Sci 1981;20:255-7.
18. Varnell RJ, Freeman JY, Maitchouk D, Beuerman RW, Gebhardt BM. Detection of substance P in human tears by laser desorption mass spectrometry and immunoassay. Curr Eye Res 1997;16:960-3.
19. Yamada M, Ogata M, Kawai M, Mashima Y, Nishida T. Substance P in human tears. Cornea 2003;22:S48-S54.
20. Baleriola-Lucas C, Fukuda M, Willcox MD, Sweeney DF, Holden BA. Fibronectin concentration in tears of contact lens wearers. Exp Eye Res 1997;64:37-43.
21. Csutak A, Silver DM, Tozser J, Facsko A, Berta A. Plasminogen activator activity and inhibition in rabbit tears after photorefractive keratectomy. Exp Eye Res 2003;77:675-80.
22. Zhou L, Huang LQ, Beuerman RW, Grigg ME, Li SF, Chew FT, Ang L, Stern ME, Tan D. Proteomic analysis of human tears: defensin expression after ocular surface surgery. J Proteome Res 2004;3:410-16.
23. Ohashi Y, Ishida R, Kojima T, Goto E, Matsumoto Y, Watanabe K, Ishida N, Nakata K, Takeuchi T, Tsubota K. Abnormal protein profiles in tears with dry eye syndrome. Am J Ophthalmol 2003;136:291-9.
24. Kari O, Aho VV, Peltonen S, Saari JM, Kari M, Maatta M, Collan Y, Saari KM. Group IIA phospholipase A (2) concentration of tears in patients with ocular rosacea. Acta Ophthalmol Scand 2005;83: 483-6.
25. Bours J, Reitz C, Strobel J, Breipohl W. Detection of secretory IgM in tears during rhino-conjunctivitis. Graefes Arch Clin Exp Ophthalmol 2005;243:456-63.
26. Tozser J, Berta A. Lactate dehydrogenase activity in pathological human tears obtained with glass capillaries correlates with the albumin content. Int Ophthalmol 1998;22:289-92.
27. Fung KY, Morris C, Sathe S, Sack R, Duncan MW. Characterization of the in vivo forms of lacrimal-specific proline-rich proteins in human tear fluid. Proteomics 2004;4:3953-9.
28. Koo BS, Lee DY, Ha HS, Kim JC, Kim CW. Comparative analysis of the tear protein expression in blepharitis patients using two-dimensional electrophoresis. J Proteome Res 2005;4:719-24.
29. de Souza GA, Godoy LM, Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol 2006;7:R72.
30. Tsai PS, Evans JE, Green KM, Sullivan RM, Schaumberg DA, Richards SM, Dana MR, Sullivan DA. Proteomic analysis of human meibomian gland secretions. Br J Ophthalmol 2006;90:372-7.
31. van Haeringen NJ, Glasius E. Enzymes of energy-producing metabolism in human tear fluid. Exp Eye Res 1974;18:407-9.
32. Kitagawa K, Tomosugi N, Tuchida H, Sasaki H. Automated identification and quantification of tear proteins in Sjögren's syndrome by LC-MS on a hybrid linear ion trap mass spectrometer. Poster presented at: 5th International Conference on the Tear Film and Ocular Surface: Basic Science and Clinical Relevance, Taormina, Sicily, Italy, September 2007;pp 5-8.
33. Green-Church KB, Sessler R, Nichols JJ. Proteomic analyses in contact lens-related dry eye. Invest Ophthalmol Vis Sci 2007;48:E-Abstract 5405.
34. Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T, Albuquerque RJ, Richter E, Sakurai E, Newcomb MT, Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A, Samuelson DA, Agnew DW, St Leger J, Green WR, Mahasreshti PJ, Curiel DT, KwanD,MarshH,IkedaS,Leiper LJ, Collinson JM, Bogdanovich S, Khurana TS, Shibuya M, Baldwin ME, Ferrara N, Gerber HP, De Falco S, Witta J, Baffi JZ, Raisler BJ, Ambati J. Corneal avascularity is due to soluble VEGF receptor-1. Nature 2006;443:993-7.
35. Fujihara T, Murakami T, Nagano T, Nakamura M, Nakata K. INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model. J Ocul Pharmacol Ther 2002;18:363-70.
36. Shafat I, Vlodavsky I, Ilan N. Characterization of mechanisms involved in secretion of active heparanase. J Biol Chem 2006;281: 23804-11.
37. Begovac PC, Hall DE, Shur BD. Laminin fragment E8 mediates PC12 cell neurite outgrowth by binding to cell surface beta 1,4 galac-tosyltransferase. J Cell Biol 1991;113:637-44.
38. Bernauer W, Thiel MA, Langenauer UM, Rentsch KM. Phosphate concentration in artificial tears. Graefes Arch Clin Exp Ophthalmol 2006;244:1010-14.
39. Aktaçs Z, Ozdek S, Asli Dinç U, Akyürek N, Atalay V, Güz G, Hasanreisoglu B. Alterations in ocular surface and corneal thickness in relation to metabolic control in patients with chronic renal failure. Nephrology (Carlton) 2007;12:380-5.
40. Watanabe M, Kondo S, Mizuno K, Yano W, Nakao H, Hattori Y, Kimura K, Nishida T. Promotion of corneal epithelial wound healing in vitro and in vivo by annexin A5. Invest Ophthalmol Vis Sci 2006; 47:1862-8.
41. Staikou EV, Routsias JG, Makri AA, Terzoglou A, Sakarellos-Daitsiotis M, Sakarellos C, Panayotou G, Moutsopoulos HM, Tzioufas AG. Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies. Clin Exp Immunol 2003;134:143-50.
42. Raje CI, Kumar S, Harle A, Nanda JS, Raje M. The macrophage cell surface glyceraldehyde-3-phosphate dehydrogenase is a novel trans-ferrin receptor. J Biol Chem 2007;282:3252-61.
43. Cao Z, Said N, Amin S, Wu HK, Bruce A, Garate M, Hsu DK, Kuwabara I, Liu FT, Panjwani N. Galectins-3 and-7, but not galec-tin-1, play a role in re-epithelialization of wounds. J Biol Chem 2002; 277:42299-305.
44. Chen Z, de Paiva CS, Luo L, Kretzer FL, Pflugfelder SC, Li DQ. Characterization of putative stem cell phenotype in human limbal epithelia. Stem Cells 2004;22:355-66.
45. Ma P, Beck SL, Raab RW, McKown RL, Coffman GL, Utani A, Chirico WJ, Rapraeger AC, Laurie GW. Heparanase deglycanation of syndecan-1 is required for binding of the epithelial-restricted prosecretory mitogen lacritin. J Cell Biol 2006;174:1097-106.
46. Kennedy MW, Heikema AP, Cooper A, Bjorkman PJ, Sanchez LM. Hydrophobic ligand binding by Zn-alpha 2-glycoprotein, a soluble fat-depleting factor related to major histocompatibility complex proteins. J Biol Chem 2001;276:35008-13.
47. Vijayakumar S, Takito J, Gao X, Schwartz GJ, Al-Awqati Q. Differentiation of columnar epithelia: the hensin pathway. J Cell Sci 2006; 119:4797-801.
48. Schulz BL, Oxley D, Packer NH, Karlsson NG. Identification of two highly sialylated human tear-fluid DMBT1 isoforms: the major high-molecular-mass glycoproteins in human tears. Biochem J 2002;366: 511-20.
49. Smith S, Hassell JR. Focus on molecules: perlecan (HSPG2). Exp Eye Res 2006;83:471-2.
50. Gasymov OK, Abduragimov AR, Merschak P, Redl B, Glasgow BJ. Oligomeric state of lipocalin-1 (LCN1) by multiangle laser light scattering and fluorescence anisotropy decay. Biochim Biophys Acta 2007;1774:1307-15.
51. Kimura K, Hattori A, Usui Y, Kitazawa K, Naganuma M, Kawamoto K, Teranishi S, Nomizu M, Nishida T. Stimulation of corneal epithelial migration by a synthetic peptide (PHSRN) corresponding to the second cell-binding site of fibronectin. Invest Ophthalmol Vis Sci 2007;48:1110-18.
52. Nielsen K, Vorum H, Fagerholm P, Birkenkamp-Demtroder K, Honore B, Ehlers N, Orntoft TF. Proteome profiling of corneal epithelium and identification of marker proteins for keratoconus, a pilot study. Exp Eye Res 2006;82:201-9.
53. Katz S, Hukkanen M, Lounatmaa K, Rousselle P, Tervo T, Virtanen I. Cooperation of isoforms of laminin-332 and tenascin-CL during early adhesion and spreading of immortalized human corneal epithelial cells. Exp Eye Res 2006;83:1412-22.
54. Suda T, Arai F, Shimmura S. Regulation of stem cells in the niche. Cornea 2005;24:S12-S17.
55. Dell S, Peters S, Muther P, Kociok N, Joussen AM. The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogen-esis of corneal neovascularization. Invest Ophthalmol Vis Sci 2006; 47:1928-37.
56. Tepavcevic V, Hodges RR, Zoukhri D, Dartt DA. Signal transduc-tion pathways used by EGF to stimulate protein secretion in rat lacrimal gland. Invest Ophthalmol Vis Sci 2003;44:1075-81.
57. Sharma GD, Kakazu A, Bazan HE. Protein kinase C alpha and epsi-lon differentially modulate hepatocyte growth factor-induced epithelial proliferation and migration. Exp Eye Res 2007;85:289-97.
58. Ma P, Wang N, McKown RL, Raab RW, Laurie GW. Focus on molecules: lacritin. Exp Eye Res 2008;86:457-8.
59. Wang J, Wang N, Xie J, Walton SC, McKown RL, Raab RW, Ma P, Beck SL, Coffman GL, Hussaini IM, Laurie GW. Restricted epithelial proliferation by lacritin via PKCalpha-dependent NFAT and mTOR pathways. J Cell Biol 2006;174:689-700.
60. Sanghi S, Kumar R, Lumsden A, Dickinson D, Klepeis V, Trinkaus-Randall V, Frierson HF Jr, Laurie GW. cDNA and genomic cloning of lacritin, a novel secretion enhancing factor from the human lacri-mal gland. J Mol Biol 2001;310:127-39.
61. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004;4:45-60.
62. Traverso V, Kinkl N, Grimm L, Sahel J, Hicks D. Basic fibroblast and epidermal growth factors stimulate survival in adult porcine photore-ceptor cell cultures. Invest Ophthalmol Vis Sci 2003;44:4550-8.
63. Kakazu A, Chandrasekher G, Bazan HE. HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway. Invest Ophthalmol Vis Sci 2004;45:3485-92.
64. Nakamura T, Nishida K, Dota A, Kinoshita S. Changes in conjunc-tival clusterin expression in severe ocular surface disease. Invest Oph-thalmol Vis Sci 2002;43:1702-7.
65. Zenkel M, Kruse FE, Junemann AG, Naumann GO, Schlotzer-Schrehardt U. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material. Invest Ophthalmol Vis Sci 2006;47: 1982-90.
66. Blalock TD, Spurr-Michaud SJ, Tisdale AS, Heimer SR, Gilmore MS, Ramesh V, Gipson IK. Functions of MUC16 in corneal epithelial cells. Invest Ophthalmol Vis Sci 2007;48:4509-18.
67. Wisner A, Dufour E, Messaoudi M, Nejdi A, Marcel A, Ungeheuer MN, Rougeot C. Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways. Proc Natl Acad Sci USA 2006; 103:17979-84.
68. Girard JP, Springer TA. Cloning from purified high endothelial venule cells of hevin, a close relative of the antiadhesive extracellular matrix protein SPARC. Immunity 1995;2:113-23.
69. Yoon KC, Jeong IY, Park YG, Yang SY. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 2007;26:431-7.
70. Nguyen CQ, Kim H, Cornelius JG, Peck AB. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3. J Immunol 2007;179:2318-29.
71. Wu Z, Lauer TW, Sick A, Hackett SF, Campochiaro PA. Oxidative stress modulates complement factor H expression in retinal pig-mented epithelial cells by acetylation of FOXO3. J Biol Chem 2007; 282:22414-25.
72. Nakamura S, Shibuya M, Nakashima H, Hisamura R, Masuda N, Imagawa T, Uehara M, Tsubota K. Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye. Invest Ophthalmol Vis Sci 2007;48:1552-8.
73. Kawai S, Nakajima T, Hokari S, Komoda T, Kawai K. Apolipoprotein A-I concentration in tears in diabetic retinopathy. Ann Clin Biochem 2002;39:56-61.
74. Yamada J, Ksander BR, Streilein JW. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 2001;42:386-92.
75. Pflugfelder SC, Farley W, Luo L, Chen LZ, de Paiva CS, Olmos LC, Li DQ, Fini ME. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol 2005;166:61-71.
76. Tong L, Chen Z, De Paiva CS, Beuerman R, Li DQ, Pflugfelder SC. Transglutaminase participates in UVB-induced cell death pathways in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2006; 47:4295-301.
77. Arandjelovic S, Van Sant CL, Gonias SL. Limited mutations in full-length tetrameric human alpha2-macroglobulin abrogate binding of platelet-derived growth factor-BB and transforming growth factor-beta1. J Biol Chem 2006;281:17061-8.
78. Milenkovic I, Birkenmeier G, Wiedemann P, Reichenbach A, Bringmann A. Effect of alpha2-macroglobulin on retinal glial cell proliferation. Graefes Arch Clin Exp Ophthalmol 2005;243:811-16.
79. Fujihara T, Nagano T, Endo K, Nakamura M, Nakata K. Lactoferrin protects against UV-B irradiation-induced corneal epithelial damage in rats. Cornea 2000;19:207-11.
80. Araki-Sasaki K, Ando Y, Nakamura M, Kitagawa K, Ikemizu S, Kawaji T, Yamashita T, Ueda M, Hirano K, Yamada M, Matsumoto K, Kinoshita S, Tanihara H. Lactoferrin Glu561Asp facilitates secondary amyloidosis in the cornea. Br J Ophthalmol 2005;89:684-8.
81. Fluckinger M, Haas H, Merschak P, Glasgow BJ, Redl B. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob Agents Chemother 2004;48:3367-72.
82. Tomosugi N, Kitagawa K, Takahashi N, Sugai S, Ishikawa I. Diagnostic potential of tear proteomic patterns in Sjogren's syndrome. J Proteome Res 2005;4:820-5.
83. Pavlou AK, Reichert JM. Recombinant protein therapeutics - success rates, market trends and values to 2010. Nat Biotechnol 2004; 22:1513-19.
84. Li N, Wang N, Zheng J, Liu XM, Lever OW, Erickson PM, Li L. Characterization of human tear proteome using multiple proteomic analysis techniques. J Proteome Res 2005;4:2052-61.
85. Sack R, Conradi L, Beaton A, Sathe S, McNamara N, Leonardi A. Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments. Exp Eye Res 2007;85:528-38.
86. Ozyildirim AM, Wistow GJ, Gao J, Wang J, Dickinson DP, Frierson HF Jr, Laurie GW. The lacrimal gland transcriptome is an unusually rich source of rare and poorly characterized gene transcripts. Invest Ophthalmol Vis Sci 2005;46:1572-80.
87. Green-Church KB, Nichols K, Kleinholz N, Zhang L, Nichols JJ. Investigation of the human tear film proteome using multiple pro-teomic approaches. Mol Vis 2008;14:456-70.